Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 16 | ECE2008 | Next issue

10th European Congress of Endocrinology

Poster Presentations

Neuroendocrinology

Previous section
Growth factors
Table of contents
Next section
Obesity

ea0016p377 | Neuroendocrinology

Turner syndrome: body composition and psychological state

ea0016p378 | Neuroendocrinology

Can early evening melatonin treatment prevent relapse after sleep deprivation?

ea0016p379 | Neuroendocrinology

Reduction of food intake by insulin detemir in comparison to regular human insulin

ea0016p380 | Neuroendocrinology

Pituitary insufficiency after traumatic brain injury and the coherence with psychological disorders

ea0016p381 | Neuroendocrinology

Review of pituitary adenomas diagnosed in Burgos (Spain)

ea0016p382 | Neuroendocrinology

Residual adverse vascular risk and oxidative stress in treated adult panhypopituitarism

ea0016p383 | Neuroendocrinology

Is total and acylated ghrelin secretion after oral glucose modified by acromegaly?

ea0016p384 | Neuroendocrinology

Hypothalamic–pituitary insufficiency following infectious diseases of the central nervous system

ea0016p385 | Neuroendocrinology

The choice of therapy in acromegaly: results of treatment at a tertiary care hospital

ea0016p386 | Neuroendocrinology

Isolated GH deficiency of adult-onset in the KIMS database: prevalence, clinical presentation, and response to GH replacement

ea0016p387 | Neuroendocrinology

Efficacy of slow release formulation of lanreotide (Somatuline Autogel® 120 mg) in patients with acromegaly: single center experience

ea0016p388 | Neuroendocrinology

Smoking causes increased androgen levels in perimenopausal women

ea0016p389 | Neuroendocrinology

Body fat excess and GH-stimulated levels in adult patients with Prader–Willi syndrome

ea0016p390 | Neuroendocrinology

Cardiovascular risk factors in adult onset growth hormone deficiency (AO-GHD) without growth hormone replacement: follow-up period seven years

ea0016p391 | Neuroendocrinology

Nocturnal HPA axis activity is blunted by increased plasma glucose concentrations

ea0016p392 | Neuroendocrinology

Macroprolactinemia seems to have a positive effect on platelet activation through ADP stimulation

ea0016p393 | Neuroendocrinology

A study of the serotoninergic tone in healthy subjects and diabetic patients treated by a clinical-paedagogic approach (Group Care) or traditional care

ea0016p394 | Neuroendocrinology

Growth hormone (GH) treatment on atherosclerosis: results of a 5 years open, prospective, controlled study in male patients with severe GH deficiency

ea0016p395 | Neuroendocrinology

Dopamine receptor expression and dopamine agonist effectiveness in corticotroph pituitary tumors: comparison with clinical, biochemical radiological and pathological features of patients with Cushing's disease

ea0016p396 | Neuroendocrinology

The effects of growth hormone deficiency following moderate and severe traumatic brain injury on cognitive functions

ea0016p397 | Neuroendocrinology

Pharmacological prevention of long-term neuroendocrine and behavioral changes in prenatally stressed rats

ea0016p398 | Neuroendocrinology

Genetic and clinical analyses in an Italian series of idiopathic hypogonadotropic hypogonadism

ea0016p399 | Neuroendocrinology

Four years of growth hormone (GH) therapy improves markers of cardiovascular risk in GH deficient (GHD) survivors of childhood acute lymphoblastic leukaemia (ALL)

ea0016p400 | Neuroendocrinology

Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome

ea0016p401 | Neuroendocrinology

Serum and glucocorticoid-induced kinase 1 mediates basal and stimulated POMC transcription in pituitary corticotrophs

ea0016p402 | Neuroendocrinology

Effect of hyperprolactinemia in male patients consulting for sexual dysfunction

ea0016p403 | Neuroendocrinology

Effects of 6 months growth hormone treatment in GH deficient patients (GHD) long after traumatic brain injury (TBI)

ea0016p404 | Neuroendocrinology

Total and cause-specific mortality in patients from the KIMS database: direct evidence for a beneficial effect of GH replacement therapy on mortality in adult GH deficient patients

ea0016p405 | Neuroendocrinology

Performance characteristics of serum and salivary hormone quantification for luteal phase confirmation in behavioural studies

ea0016p406 | Neuroendocrinology

Malignant diseases in our patients with acromegaly

ea0016p407 | Neuroendocrinology

Pituitary abscess: a case report

ea0016p408 | Neuroendocrinology

Effects of weight gain on serum adiponectin, leptin and ghrelin concentrations in patients with anorexia nervosa

ea0016p409 | Neuroendocrinology

Evaluation of verbal memory function in acromegalic patients treated with or without conventional radiotherapy after transsphenoidal surgery

ea0016p410 | Neuroendocrinology

The role of inferior petrosal sinus sampling for ACTH-dependent Cushing's syndrome

ea0016p411 | Neuroendocrinology

Comparison of visceral adipose tissue content between diabetic and nondiabetic acromegalic patients

ea0016p412 | Neuroendocrinology

A non-functioning pituitary carcinoma with cerebellar metastases

ea0016p413 | Neuroendocrinology

Impact of hyperglycaemia on carotid intima-media thickness in acromegaly

ea0016p414 | Neuroendocrinology

Autoimmune hypophysitis and isolated corticotrophin deficiency

ea0016p415 | Neuroendocrinology

Heel pad thickness in diabetic and nondiabetic acromegalic patients

ea0016p416 | Neuroendocrinology

Perioperative steroid treatment is not routinely required in endoscopic transphenoidal surgery for clinically non functioning pituitary adenomas (NFPA)

ea0016p417 | Neuroendocrinology

Pituitary deficiencies after autologous bone marrow transplantation

ea0016p418 | Neuroendocrinology

Consequences of isolation stress on glucocorticoid regulating genes and behavioural response in postnatal pigs

ea0016p419 | Neuroendocrinology

Demography, characteristics and outcome of acromegaly at King Hussein medical centre amman Jordan

ea0016p420 | Neuroendocrinology

Sleep quality in patients of a primary health care unit and its relationships with antropometric parametters

ea0016p421 | Neuroendocrinology

Glucose-dependent insulinotropic polypeptide receptor (GIPR) in human pituitary adenomas

ea0016p422 | Neuroendocrinology

Macroprolactinaemia in men

ea0016p423 | Neuroendocrinology

Age-dependent expression of ret receptor from perinatal life to adulthood

ea0016p424 | Neuroendocrinology

Midnight salivary cortisol (MSC) to assess the outcome of transsphenoidal surgery (TSS) in Cushing's disease (CD)

ea0016p425 | Neuroendocrinology

Tests of growth hormone (GH) status in severe GH deficiency: do they identify a similar phenotype? Insight from the KIMS database

ea0016p426 | Neuroendocrinology

Enos, P22phox and apoE gene polymorphism associations with circulating hormone levels in the elderly

ea0016p427 | Neuroendocrinology

Is increase in bone mineral content caused by increase in skeletal muscle mass/strength in adult patients with growth hormone (GH) treated GH deficiency? A litterature analysis

ea0016p428 | Neuroendocrinology

Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor (SSRI), during lifespan in humans

ea0016p429 | Neuroendocrinology

Variable effects of preproTRH(178–199) on ACTH secretion by human corticotrope tumors

ea0016p430 | Neuroendocrinology

Endocrine features of aging and cognitive function in women

ea0016p431 | Neuroendocrinology

Effect of a six-month treatment with octreotide long acting repeatable (LAR) on mean platelet volume in patients with acromegaly

ea0016p432 | Neuroendocrinology

GHRH as a possible allosteric ligand of the ghrelin receptor GHS-R1a

ea0016p433 | Neuroendocrinology

Unusual pattern of pituitary insufficiencies following traumatic brain injury evaluated by insulin tolerance test

ea0016p434 | Neuroendocrinology

Hypopituitarism and features of the metabolic syndrome in patients with traumatic brain injury (TBI)

ea0016p435 | Neuroendocrinology

Lymphocytic infundibulo-neurohypophysitis with diabetes insipidus and favorable evolution after glucocorticoid treatment

ea0016p436 | Neuroendocrinology

Prolactin levels in patients with cirrhosis increase with severity of liver disease

ea0016p437 | Neuroendocrinology

Pituitary dysfunction in patients after stroke

ea0016p438 | Neuroendocrinology

Abstract unavailable

ea0016p439 | Neuroendocrinology

A comparison between three automated chemiluminescence assays for growth hormone: on the use of recombinant hGH as a primary calibrant

ea0016p440 | Neuroendocrinology

Acute effects of the intranasal administration of growth hormone-releasing hormone (GHRH) on nocturnal memory consolidation in waking young men

ea0016p441 | Neuroendocrinology

Cardiovascular risk profile in 81 acromegalic patients: a cross-sectional clinical study

ea0016p442 | Neuroendocrinology

Diurnal cortisol profile changes in the acute phase after aneurysmal subarachnoid hemorrhage

ea0016p443 | Neuroendocrinology

Pregnancy in the rat is a physiological state of leptin resistance

ea0016p444 | Neuroendocrinology

Effects of intranasal atrial natriutetic peptide (ANP) and insulin on sleep-associated pituitary–adrenal inhibition in elderly humans

ea0016p445 | Neuroendocrinology

Long-term treatment with dopamine agonists is not associated with increased prevalence of valvular heart disease in patients with prolactinomas

ea0016p446 | Neuroendocrinology

Expansion of grey and white matter volumes and increased white matter gliosis in acromegaly: a clinicoradiological study of 43 patients

ea0016p447 | Neuroendocrinology

GH response to GH-releasing hormone–arginine (GHRH+Arg) is impaired in women affected by human immunodeficiency virus (HIV)-related lipodystrophy

ea0016p448 | Neuroendocrinology

Glucose infusion affects memory function but not ACTH concentrations in patients with Addison's disease

ea0016p449 | Neuroendocrinology

Prevalence of metabolic syndrome in adult hypopituitaric patients with GH deficiency (GHD)

ea0016p450 | Neuroendocrinology

The benefit of long-term growth hormone replacement therapy in adults, results of the German KIMS database

ea0016p451 | Neuroendocrinology

Panhypopituitarism due to hemochromatosis: a case report

ea0016p452 | Neuroendocrinology

Pituitary autoantibodies in patients with central diabetes insipidus and polydipsia: evidence of autoimmune pituitary involvement in both states

ea0016p453 | Neuroendocrinology

Endocrinopathies with langerhans cell histiocytosis (LCH): nine cases

ea0016p454 | Neuroendocrinology

Aryl hydrocarbon receptor interacting protein (AIP) expression in human pituitary adenomas

ea0016p455 | Neuroendocrinology

Systemic comorbidities induce early vascular alterations in patients with active acromegaly

ea0016p456 | Neuroendocrinology

Use of videocapsule endoscopy (VCE) for the detection of small bowel tumors in patients with acromegaly

ea0016p457 | Neuroendocrinology

Fatigue in breast cancer patients during chemotherapy: correlation with neuromuscular dysfunction and IGF-1 plasma levels

ea0016p458 | Neuroendocrinology

Effect of GH replacement on coronary flow reserve (CFR) and on some cardiovascular risk factors in adult GHD patients

ea0016p459 | Neuroendocrinology

Effect of cholescytokinin (CCK) on food intake and brainstem and hypothalamic neuronal activation and its modulation by glucocorticoid

ea0016p460 | Neuroendocrinology

Intrasellar and parasellar tumors – concomitant symptoms and clinical syndromes

ea0016p461 | Neuroendocrinology

d3-growth hormone receptor polymorphism (d3-GHR) is associated with low BMI and better glucose metabolism in acromegaly

ea0016p462 | Neuroendocrinology

Correlation of IGF-1 and IGFBP-3 levels with liver function in patients following traumatic brain injury or subarachnoidal haemorrhage

ea0016p463 | Neuroendocrinology

Identification and molecular characterization of new somatostatin receptor subtype 5 truncated isoforms in rodents

ea0016p464 | Neuroendocrinology

Posttraumatic hypopituitarism is associated with an unfavorable body composition and lipid profile, and decreased quality of life 12 months after injury

ea0016p465 | Neuroendocrinology

Gh/Igf-1 control and tumor growth reduction in active acromegalic patients on Octreotide LAR

ea0016p466 | Neuroendocrinology

Effects of growth hormone replacement in 28 patients with growth hormone deficiency

ea0016p467 | Neuroendocrinology

Starting dose of 10 mg Octreotide-LAR appears ineffective for biochemical control in the majority of acromegalic patients: interim analysis from the OASIS trial

ea0016p468 | Neuroendocrinology

Factors associated with response to medical therapy in patients with Acromegaly

ea0016p469 | Neuroendocrinology

Diagnosis of SIAD: Fractional urate excretion closes the diagnostic gap in hyponatremic patients on diuretics

ea0016p470 | Neuroendocrinology

Circulating visfatin and adiponectin levels are reduced in women after long-term remission of Cushing's syndrome

ea0016p471 | Neuroendocrinology

The impact of conventional radiotherapy on Wisconsin card sorting test performance in acromegalic patients treated with transsphenoidal surgery

ea0016p472 | Neuroendocrinology

Somatotropin release inhibiting factor (SRIF) downregulates Wnt/ß-catenin pathway in ACTH-secreting pituitary cell line AtT-20

ea0016p473 | Neuroendocrinology

Identification of ACTH-secreting adenomas in Cushing's disease using intraoperative high-frequency direct contact ultrasound. Preleminary results

ea0016p474 | Neuroendocrinology

Macroprolactinaemia: a clinical problem

ea0016p475 | Neuroendocrinology

Prolaktinoma and hyperprolactinemia in Albania

ea0016p476 | Neuroendocrinology

Prospective comparison of the glucagon stimulation test (GST) with the insulin tolerance test (ITT) in patients following pituitary surgery

ea0016p477 | Neuroendocrinology

Expression of ghrelin and opioid mRNAs in the hypothalamo–pituitary–adrenal axis after immune system activation

ea0016p478 | Neuroendocrinology

Cyclical Cushing's syndrome: prevalence in patients with Cushing's disease

ea0016p479 | Neuroendocrinology

Familial acromegaly: family screening and assessment in the familial isolated pituitary adenoma (FIPA)

ea0016p480 | Neuroendocrinology

Hypopituitarism following traumatism brain injury in the West Indies: a pilot study between July 2005 and July 2006

ea0016p481 | Neuroendocrinology

Hypopituitarism after traumatic brain injury and its possible relation with neurocognitive and psychiatric disturbances

ea0016p482 | Neuroendocrinology

Endoscopic pituitary surgery as the primary treatment for acromegaly: a prospective study in a specialised centre

ea0016p483 | Neuroendocrinology

mTOR inhibitors rapamycin and RAD001 (Everolimus) induce antiproliferative effects in GH3 cell line and human pituitary adenomas

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more